nodes	percent_of_prediction	percent_of_DWPC	metapath
Theobromine—PDE4B—hematologic cancer	0.505	1	CbGaD
Theobromine—CYP1A2—Anagrelide—hematologic cancer	0.0591	0.149	CbGbCtD
Theobromine—CYP2E1—Thalidomide—hematologic cancer	0.0378	0.0953	CbGbCtD
Theobromine—CYP2E1—Dacarbazine—hematologic cancer	0.0325	0.082	CbGbCtD
Theobromine—CYP1A2—Carmustine—hematologic cancer	0.0311	0.0782	CbGbCtD
Theobromine—CYP1A2—Methoxsalen—hematologic cancer	0.0264	0.0665	CbGbCtD
Theobromine—CYP2E1—Mitoxantrone—hematologic cancer	0.0252	0.0636	CbGbCtD
Theobromine—CYP1A2—Bortezomib—hematologic cancer	0.0251	0.0633	CbGbCtD
Theobromine—CYP1A2—Daunorubicin—hematologic cancer	0.024	0.0605	CbGbCtD
Theobromine—CYP1A2—Alitretinoin—hematologic cancer	0.0235	0.0593	CbGbCtD
Theobromine—CYP1A2—Thalidomide—hematologic cancer	0.0219	0.0551	CbGbCtD
Theobromine—CYP1A2—Dacarbazine—hematologic cancer	0.0188	0.0474	CbGbCtD
Theobromine—CYP1A2—Imatinib—hematologic cancer	0.0184	0.0464	CbGbCtD
Theobromine—CYP2E1—Etoposide—hematologic cancer	0.0159	0.0401	CbGbCtD
Theobromine—CYP1A2—Dasatinib—hematologic cancer	0.0148	0.0372	CbGbCtD
Theobromine—CYP2E1—Dexamethasone—hematologic cancer	0.0131	0.033	CbGbCtD
Theobromine—CYP1A2—Etoposide—hematologic cancer	0.00921	0.0232	CbGbCtD
Theobromine—ADORA2A—hematopoietic system—hematologic cancer	0.00284	0.101	CbGeAlD
Theobromine—ADORA1—hematopoietic system—hematologic cancer	0.00246	0.0868	CbGeAlD
Theobromine—ADORA2A—gonad—hematologic cancer	0.00216	0.0764	CbGeAlD
Theobromine—ADORA2A—blood—hematologic cancer	0.00188	0.0666	CbGeAlD
Theobromine—PDE4B—hematopoietic system—hematologic cancer	0.00182	0.0642	CbGeAlD
Theobromine—ADORA2A—testis—hematologic cancer	0.00156	0.0551	CbGeAlD
Theobromine—ADORA1—lung—hematologic cancer	0.00143	0.0504	CbGeAlD
Theobromine—PDE4B—gonad—hematologic cancer	0.00138	0.0488	CbGeAlD
Theobromine—ADORA1—testis—hematologic cancer	0.00135	0.0476	CbGeAlD
Theobromine—PDE4B—blood—hematologic cancer	0.0012	0.0425	CbGeAlD
Theobromine—PDE4B—bone marrow—hematologic cancer	0.00116	0.0412	CbGeAlD
Theobromine—CYP1A2—hematopoietic system—hematologic cancer	0.00112	0.0394	CbGeAlD
Theobromine—PDE4B—lung—hematologic cancer	0.00105	0.0373	CbGeAlD
Theobromine—Enprofylline—PDE4B—hematologic cancer	0.00101	0.14	CrCbGaD
Theobromine—CYP2E1—hematopoietic system—hematologic cancer	0.001	0.0355	CbGeAlD
Theobromine—PDE4B—testis—hematologic cancer	0.000995	0.0352	CbGeAlD
Theobromine—Caffeine—ATM—hematologic cancer	0.000992	0.138	CrCbGaD
Theobromine—ADORA1—lymph node—hematologic cancer	0.000975	0.0345	CbGeAlD
Theobromine—Caffeine—PIK3CB—hematologic cancer	0.000907	0.126	CrCbGaD
Theobromine—Caffeine—PIK3CD—hematologic cancer	0.000907	0.126	CrCbGaD
Theobromine—CYP1A2—blood—hematologic cancer	0.000739	0.0261	CbGeAlD
Theobromine—Theophylline—HDAC2—hematologic cancer	0.00073	0.102	CrCbGaD
Theobromine—PDE4B—lymph node—hematologic cancer	0.000721	0.0255	CbGeAlD
Theobromine—Caffeine—PIK3CA—hematologic cancer	0.000702	0.0975	CrCbGaD
Theobromine—CYP2E1—blood—hematologic cancer	0.000665	0.0235	CbGeAlD
Theobromine—CYP1A2—lung—hematologic cancer	0.000648	0.0229	CbGeAlD
Theobromine—Pentoxifylline—PDE4B—hematologic cancer	0.000631	0.0878	CrCbGaD
Theobromine—CYP2E1—lung—hematologic cancer	0.000583	0.0206	CbGeAlD
Theobromine—CYP2E1—testis—hematologic cancer	0.00055	0.0194	CbGeAlD
Theobromine—Dyphylline—PDE4B—hematologic cancer	0.000512	0.0712	CrCbGaD
Theobromine—Theophylline—PDE4B—hematologic cancer	0.000365	0.0507	CrCbGaD
Theobromine—Caffeine—PDE4B—hematologic cancer	0.000358	0.0498	CrCbGaD
Theobromine—Caffeine—ABCB1—hematologic cancer	8.19e-05	0.0114	CrCbGaD
Theobromine—PDE4B—Signaling Pathways—NFKBIA—hematologic cancer	1.24e-05	0.000197	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—BAD—hematologic cancer	1.24e-05	0.000197	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FOXO1—hematologic cancer	1.23e-05	0.000195	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—IL2—hematologic cancer	1.23e-05	0.000195	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PDGFRB—hematologic cancer	1.23e-05	0.000195	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—NOTCH1—hematologic cancer	1.23e-05	0.000195	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NUP98—hematologic cancer	1.22e-05	0.000194	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CD80—hematologic cancer	1.22e-05	0.000193	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CB—hematologic cancer	1.21e-05	0.000193	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CG—hematologic cancer	1.21e-05	0.000193	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—KIT—hematologic cancer	1.21e-05	0.000193	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—NRAS—hematologic cancer	1.21e-05	0.000193	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PDGFRA—hematologic cancer	1.21e-05	0.000192	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—JAK1—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PRKCG—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTAP—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CD80—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CG—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—KIT—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—NRAS—hematologic cancer	1.2e-05	0.000191	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PTPN11—hematologic cancer	1.19e-05	0.00019	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ADCY7—hematologic cancer	1.18e-05	0.000188	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NCOA3—hematologic cancer	1.18e-05	0.000188	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PTPN11—hematologic cancer	1.18e-05	0.000187	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NUP214—hematologic cancer	1.17e-05	0.000187	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—MAPK3—hematologic cancer	1.16e-05	0.000185	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CREB1—hematologic cancer	1.15e-05	0.000184	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ABCG2—hematologic cancer	1.15e-05	0.000183	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MTR—hematologic cancer	1.15e-05	0.000183	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—MAPK3—hematologic cancer	1.15e-05	0.000183	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CREB1—hematologic cancer	1.14e-05	0.000181	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—BRAF—hematologic cancer	1.14e-05	0.000181	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCL2—hematologic cancer	1.13e-05	0.00018	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ENO2—hematologic cancer	1.13e-05	0.000179	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—BRAF—hematologic cancer	1.13e-05	0.000179	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6R—hematologic cancer	1.13e-05	0.000179	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CREBBP—hematologic cancer	1.12e-05	0.000179	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL2RA—hematologic cancer	1.12e-05	0.000179	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCL2—hematologic cancer	1.12e-05	0.000178	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL2—hematologic cancer	1.12e-05	0.000177	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6R—hematologic cancer	1.11e-05	0.000177	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TERT—hematologic cancer	1.11e-05	0.000177	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CREBBP—hematologic cancer	1.11e-05	0.000177	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTT1—hematologic cancer	1.09e-05	0.000174	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PDGFB—hematologic cancer	1.08e-05	0.000173	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAP2K1—hematologic cancer	1.07e-05	0.000171	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—FHL2—hematologic cancer	1.07e-05	0.000171	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—SDC1—hematologic cancer	1.07e-05	0.00017	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CD—hematologic cancer	1.07e-05	0.00017	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAP2K1—hematologic cancer	1.06e-05	0.000169	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TSC2—hematologic cancer	1.06e-05	0.000169	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.06e-05	0.000168	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CD—hematologic cancer	1.05e-05	0.000168	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—AGRN—hematologic cancer	1.05e-05	0.000167	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—KRAS—hematologic cancer	1.04e-05	0.000166	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—PIK3CA—hematologic cancer	1.04e-05	0.000166	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—KRAS—hematologic cancer	1.03e-05	0.000164	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—FGF2—hematologic cancer	1.02e-05	0.000162	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FGFR3—hematologic cancer	1.02e-05	0.000162	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK14—hematologic cancer	1.01e-05	0.000161	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—FGF2—hematologic cancer	1.01e-05	0.00016	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3R1—hematologic cancer	1.01e-05	0.00016	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—IDH2—hematologic cancer	9.97e-06	0.000159	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HMMR—hematologic cancer	9.97e-06	0.000159	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3R1—hematologic cancer	9.95e-06	0.000158	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—ESR1—hematologic cancer	9.91e-06	0.000158	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—JAK2—hematologic cancer	9.79e-06	0.000156	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FN1—hematologic cancer	9.79e-06	0.000156	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NFKBIA—hematologic cancer	9.67e-06	0.000154	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—BAD—hematologic cancer	9.67e-06	0.000154	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—JAK2—hematologic cancer	9.67e-06	0.000154	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—PIK3CA—hematologic cancer	9.59e-06	0.000153	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NOTCH1—hematologic cancer	9.58e-06	0.000152	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MDM2—hematologic cancer	9.55e-06	0.000152	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—PIK3CA—hematologic cancer	9.48e-06	0.000151	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MDM2—hematologic cancer	9.44e-06	0.00015	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.4e-06	0.00015	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CD80—hematologic cancer	9.38e-06	0.000149	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ARNTL—hematologic cancer	9.37e-06	0.000149	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CG—hematologic cancer	9.36e-06	0.000149	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KIT—hematologic cancer	9.36e-06	0.000149	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—NRAS—hematologic cancer	9.36e-06	0.000149	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MTOR—hematologic cancer	9.29e-06	0.000148	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CB—hematologic cancer	9.29e-06	0.000148	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PTPN11—hematologic cancer	9.2e-06	0.000146	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CB—hematologic cancer	9.18e-06	0.000146	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MTOR—hematologic cancer	9.18e-06	0.000146	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CA9—hematologic cancer	9.12e-06	0.000145	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ACP5—hematologic cancer	9.12e-06	0.000145	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NQO1—hematologic cancer	9.09e-06	0.000145	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CD44—hematologic cancer	9.09e-06	0.000145	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOR2—hematologic cancer	9e-06	0.000143	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—MAPK3—hematologic cancer	8.97e-06	0.000143	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CREB1—hematologic cancer	8.91e-06	0.000142	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—HRAS—hematologic cancer	8.87e-06	0.000141	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—BRAF—hematologic cancer	8.8e-06	0.00014	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—HRAS—hematologic cancer	8.77e-06	0.000139	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCL2—hematologic cancer	8.72e-06	0.000139	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CDKN1B—hematologic cancer	8.72e-06	0.000139	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6R—hematologic cancer	8.7e-06	0.000138	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CREBBP—hematologic cancer	8.68e-06	0.000138	CbGpPWpGaD
Theobromine—ADORA1—GPCR downstream signaling—AKT1—hematologic cancer	8.63e-06	0.000137	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CDKN1B—hematologic cancer	8.62e-06	0.000137	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CYCS—hematologic cancer	8.6e-06	0.000137	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—IDH1—hematologic cancer	8.57e-06	0.000136	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CASP3—hematologic cancer	8.55e-06	0.000136	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	8.54e-06	0.000136	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL2—hematologic cancer	8.54e-06	0.000136	CbGpPWpGaD
Theobromine—PDE4B—GPCR downstream signaling—AKT1—hematologic cancer	8.53e-06	0.000136	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—IL6—hematologic cancer	8.49e-06	0.000135	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—TXN—hematologic cancer	8.48e-06	0.000135	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCC3—hematologic cancer	8.48e-06	0.000135	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTO1—hematologic cancer	8.48e-06	0.000135	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CASP3—hematologic cancer	8.45e-06	0.000134	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL2—hematologic cancer	8.43e-06	0.000134	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—IL6—hematologic cancer	8.39e-06	0.000133	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CCND1—hematologic cancer	8.32e-06	0.000132	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—JUN—hematologic cancer	8.3e-06	0.000132	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SPHK1—hematologic cancer	8.29e-06	0.000132	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAP2K1—hematologic cancer	8.29e-06	0.000132	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CD—hematologic cancer	8.23e-06	0.000131	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CCND1—hematologic cancer	8.22e-06	0.000131	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—JUN—hematologic cancer	8.2e-06	0.00013	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	8.15e-06	0.00013	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—KRAS—hematologic cancer	8.06e-06	0.000128	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—CDKN1A—hematologic cancer	8.05e-06	0.000128	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PTEN—hematologic cancer	8.03e-06	0.000128	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	7.97e-06	0.000127	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—CDKN1A—hematologic cancer	7.95e-06	0.000127	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PTEN—hematologic cancer	7.94e-06	0.000126	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—FGF2—hematologic cancer	7.88e-06	0.000125	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK8—hematologic cancer	7.86e-06	0.000125	CbGpPWpGaD
Theobromine—ADORA1—Signaling by GPCR—AKT1—hematologic cancer	7.83e-06	0.000125	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3R1—hematologic cancer	7.77e-06	0.000124	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK8—hematologic cancer	7.76e-06	0.000123	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CRABP1—hematologic cancer	7.75e-06	0.000123	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	7.75e-06	0.000123	CbGpPWpGaD
Theobromine—PDE4B—Signaling by GPCR—AKT1—hematologic cancer	7.74e-06	0.000123	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—EP300—hematologic cancer	7.66e-06	0.000122	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTP1—hematologic cancer	7.58e-06	0.000121	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—EP300—hematologic cancer	7.57e-06	0.00012	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—JAK2—hematologic cancer	7.56e-06	0.00012	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ALOX5—hematologic cancer	7.55e-06	0.00012	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—SRC—hematologic cancer	7.45e-06	0.000118	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—PIK3CA—hematologic cancer	7.4e-06	0.000118	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MDM2—hematologic cancer	7.38e-06	0.000117	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—SRC—hematologic cancer	7.36e-06	0.000117	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NUP98—hematologic cancer	7.32e-06	0.000116	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—VEGFA—hematologic cancer	7.25e-06	0.000115	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—STAT3—hematologic cancer	7.18e-06	0.000114	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MTOR—hematologic cancer	7.18e-06	0.000114	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CB—hematologic cancer	7.18e-06	0.000114	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ABCB1—hematologic cancer	7.17e-06	0.000114	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—VEGFA—hematologic cancer	7.17e-06	0.000114	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—NRAS—hematologic cancer	7.16e-06	0.000114	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ADCY7—hematologic cancer	7.1e-06	0.000113	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOA3—hematologic cancer	7.1e-06	0.000113	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—STAT3—hematologic cancer	7.1e-06	0.000113	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—NRAS—hematologic cancer	7.08e-06	0.000113	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NUP214—hematologic cancer	7.05e-06	0.000112	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.98e-06	0.000111	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—NCOR1—hematologic cancer	6.96e-06	0.000111	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—GSTM1—hematologic cancer	6.96e-06	0.000111	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTR—hematologic cancer	6.91e-06	0.00011	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCG2—hematologic cancer	6.91e-06	0.00011	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MAPK3—hematologic cancer	6.86e-06	0.000109	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—HRAS—hematologic cancer	6.85e-06	0.000109	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MAPK3—hematologic cancer	6.78e-06	0.000108	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ENO2—hematologic cancer	6.78e-06	0.000108	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CDKN1B—hematologic cancer	6.73e-06	0.000107	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—MYC—hematologic cancer	6.67e-06	0.000106	CbGpPWpGaD
Theobromine—ADORA2A—GPCR downstream signaling—AKT1—hematologic cancer	6.66e-06	0.000106	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TGFB1—hematologic cancer	6.66e-06	0.000106	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CASP3—hematologic cancer	6.6e-06	0.000105	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—MYC—hematologic cancer	6.59e-06	0.000105	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL2—hematologic cancer	6.59e-06	0.000105	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TGFB1—hematologic cancer	6.58e-06	0.000105	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTT1—hematologic cancer	6.57e-06	0.000105	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—IL6—hematologic cancer	6.56e-06	0.000104	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.47e-06	0.000103	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CCND1—hematologic cancer	6.42e-06	0.000102	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—SDC1—hematologic cancer	6.42e-06	0.000102	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—JUN—hematologic cancer	6.41e-06	0.000102	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—CDKN1A—hematologic cancer	6.21e-06	9.88e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PTEN—hematologic cancer	6.2e-06	9.86e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—KRAS—hematologic cancer	6.17e-06	9.81e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—MTHFR—hematologic cancer	6.15e-06	9.79e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.14e-06	9.76e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—KRAS—hematologic cancer	6.09e-06	9.69e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK8—hematologic cancer	6.07e-06	9.65e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.06e-06	9.63e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling by GPCR—AKT1—hematologic cancer	6.05e-06	9.62e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—EP300—hematologic cancer	5.91e-06	9.41e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.79e-06	9.22e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—SRC—hematologic cancer	5.75e-06	9.15e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—PIK3CA—hematologic cancer	5.67e-06	9.01e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—VEGFA—hematologic cancer	5.6e-06	8.91e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—PIK3CA—hematologic cancer	5.6e-06	8.9e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—STAT3—hematologic cancer	5.55e-06	8.82e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—NRAS—hematologic cancer	5.53e-06	8.8e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—TP53—hematologic cancer	5.48e-06	8.72e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NQO1—hematologic cancer	5.46e-06	8.69e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CD44—hematologic cancer	5.46e-06	8.69e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—TP53—hematologic cancer	5.42e-06	8.61e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.35e-06	8.51e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MAPK3—hematologic cancer	5.3e-06	8.43e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—HRAS—hematologic cancer	5.24e-06	8.34e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—HRAS—hematologic cancer	5.18e-06	8.24e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	5.17e-06	8.22e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CYCS—hematologic cancer	5.17e-06	8.22e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—MYC—hematologic cancer	5.15e-06	8.2e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TGFB1—hematologic cancer	5.14e-06	8.18e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	5.14e-06	8.17e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—IL6—hematologic cancer	5.02e-06	7.98e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—IL6—hematologic cancer	4.96e-06	7.88e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—CREBBP—hematologic cancer	4.79e-06	7.62e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—KRAS—hematologic cancer	4.76e-06	7.57e-05	CbGpPWpGaD
Theobromine—ADORA1—Signaling Pathways—AKT1—hematologic cancer	4.63e-06	7.36e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.62e-06	7.35e-05	CbGpPWpGaD
Theobromine—PDE4B—Signaling Pathways—AKT1—hematologic cancer	4.57e-06	7.27e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.56e-06	7.25e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	4.55e-06	7.23e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—ALB—hematologic cancer	4.49e-06	7.14e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.41e-06	7.01e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—PIK3CA—hematologic cancer	4.37e-06	6.96e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.31e-06	6.86e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	4.29e-06	6.83e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—TP53—hematologic cancer	4.23e-06	6.73e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.19e-06	6.66e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.19e-06	6.66e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—HRAS—hematologic cancer	4.05e-06	6.44e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.96e-06	6.3e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—IL6—hematologic cancer	3.87e-06	6.16e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.7e-06	5.88e-05	CbGpPWpGaD
Theobromine—ADORA2A—Signaling Pathways—AKT1—hematologic cancer	3.57e-06	5.68e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PTEN—hematologic cancer	3.42e-06	5.45e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—EP300—hematologic cancer	3.26e-06	5.19e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.26e-06	5.19e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.11e-06	4.94e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.88e-06	4.58e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.73e-06	4.35e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—ALB—hematologic cancer	2.7e-06	4.29e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.58e-06	4.1e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.42e-06	3.84e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.38e-06	3.79e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PTEN—hematologic cancer	2.06e-06	3.27e-05	CbGpPWpGaD
Theobromine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.97e-06	3.14e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—EP300—hematologic cancer	1.96e-06	3.12e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.45e-06	2.31e-05	CbGpPWpGaD
Theobromine—CYP1A2—Metabolism—AKT1—hematologic cancer	1.19e-06	1.89e-05	CbGpPWpGaD
